Hospitalogy

🏥 Opening the vault…

Blake Madden · FEB 19

Happy Tuesday, Hospitalogists!

 

This send is coming live to you from ViVE! 

 

Big thanks to those of you who stopped by Navina’s booth to say hi and chat about value-based care or college football, even if you aren’t rooting for Texas to be #1. Hospitalogy welcomes all takes (even the bad ones).

 

Photo evidence taken by my amazing Hospitalogy brand partner Keith Jayne: 

This only makes me cringe a little…

My New Years Resolution: Share more of the cool stuff Hospitalogy’s up to. In that spirit (and as I sprint to another session), I’m unearthing notes from three closed-door 1:1 conversations in the Hospitalogy community that have me excited about where the industry is going.

COMMUNITY ROUNDUP

Key considerations for decision makers. Notable moves, policies, and strategies

Note: Sadly, these conversations were not recorded—I hope these highlights will do them justice. The good news is that moving forward, we’re recording and uploading roundtables like these to the community. That means current and future Hospitalogy members can re-watch anything they missed. Okay, onto the good stuff:

1️⃣ Oura’s unsung super-usersCopy anchor linkCopied

Back in November, I caught up with Jason Oberfest, Oura’s VP of Healthcare, to chat about their dive into traditional healthcare (at a cool $5B valuation):

  • Why a ring? They say that, unlike wrist wearables, its ring form factor offers more accurate readings from finger arteries, including heart rate, blood oxygen, and temperature.
  • Value-Based Care Partnership: Oura’s collaboration with Essence Health integrates wearable data into clinical workflows. Members can access Oura rings as a covered benefit, possibly aiding in detecting conditions like sleep apnea, which impacts 30 million Americans.
  • The #1 thing that surprised me: Contrary to expectations, Oura’s 65+ users are more engaged than younger generations. Future focus areas include managing GLP-1 weight-loss interventions, fertility tracking, and early illness detection for vulnerable populations.

2️⃣ Aegis Ventures’ competitive edge Copy anchor linkCopied

Last fall, Aegis Ventures added UPMC and Vanderbilt Health to its consortium. I caught up with Cofounder and Managing Partner John Beadle to discuss how they’re tackling quality, equity, and cost.

  • The Model: Aegis’s digital consortium unites 30+ health systems, sharing expertise to solve common pain points like care navigation that enhance (not replace existing services.
  • The Competitive Edge: I asked, “How can health systems stay competitive amid increasing consolidation?” John’s answer: Aegis thrives on a “by systems, for systems” approach; bringing together collective expertise to tackle navigation, call centers, and care gaps without stepping on existing services. 
  • Looking Ahead: With heavyweights like Northwell Health’s Michael Dowling in their corner, they’re zeroed in on scalable, game-changing solutions in a  crowded $80B digital health market. Excited to keep an eye on them.

3️⃣ Biofourmis + CopilotIQ’s AI play Copy anchor linkCopied

I also sat down with David Koretz, CEO of Biofourmis + CopilotIQ, to dive into their big merger and hear what’s on deck for them.

  • The October Merger: Biofourmis and CopilotIQ has created the first AI-driven, end-to-end platform for in-home care. Their capabilities span pre-surgical optimization to chronic care management.
  • The Numbers: With 64M Medicare/Medicaid patients managing chronic conditions like hypertension and diabetes, the platform uses predictive analytics to optimize clinician-patient interactions and reduce hospital readmissions.
  • The ‘Aha’ Moment: Turns out, Hospital at Home and SNF (Skilled Nursing Facility) at Home programs demonstrate better outcomes, shorter stays, and lower readmissions, redefining post-acute care.

HEADLINES THIS WEEK

An abridged version

  1. Abridge secures $250M in series D (investors include CVS Health Ventures, Alphabet’s CapitalG, and Nvidia’s NVentures).
  2. CDC lacks flu and bird flu data amid rising cases.
  3. NIH’s potential cut to indirect research could cost Stanford, Vanderbilt, Weill Cornell, and UT systems $100M.
  4. A new Nature paper from Cleveland Clinic researchers: they’re seeing if AI can help identify/repurpose FDA-approved drugs for other diseases.
  5. Plus, as layoffs commence at the CDC and FDA, the whisper network points to planned layoffs afoot at United Health…

JOBS IN HEALTHCARE

The marketing team at Nabla is hiring an Events Manager. We’re looking for someone with experience in healthcare events who excels at planning and executing industry conferences, building meaningful connections, and bringing our brand to life in person.

 

If you know someone who might be a great fit, I’d love an intro—or feel free to pass this along to your network! Here's the job posting.

MISCELLANEOUS MADDENINGS

Random personal anecdotes and musings from me

Still thinking about that chat with The Cubes, aka Mark Cuban (sorry for calling him that)—namely when he said, “The first rule of PBM contracts? You don’t talk about PBM contracts.”

 

What a legend. Feeling very lucky.

Thanks for the read — stand by for my recap of ViVE 2025! Let me know what you thought by replying back to this email.

 

— Blake  

Get Hospitalogy in your inbox

The weekly read for the people running the business side of care delivery.

Written by Blake Madden

By Blake Madden

Hospitalogy

The weekly read for the people running the business side of care delivery.